发明名称 |
PROCESS FOR THE SYNTHESIS OF ETORICOXIB |
摘要 |
The present invention relates to a process for the synthesis of the anti-inflammatory agent 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridine, referred to as compound of formula (1) or etoricoxib, which is a pharmaceutically active ingredient inhibiting cyclooxygenase-2. In particular, the application concerns a novel process of making the compound of formula (1) by oxidizing a compound of formula (4).; |
申请公布号 |
US2015011771(A1) |
申请公布日期 |
2015.01.08 |
申请号 |
US201314371540 |
申请日期 |
2013.01.11 |
申请人 |
Alfred E. Tiefenbacher (GMBH & Co., KG) ;Shanghai Golden Pharmatech Co., Ltd. |
发明人 |
Mao Zhenmin;Lan Tian;Liu Lanfang;Yan Long;Becker Stefan |
分类号 |
C07D401/04 |
主分类号 |
C07D401/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A process for the preparation of etoricoxib having the formula (1)or a pharmaceutically acceptable salt thereof,comprising the method step of oxidizing a compound of formula (4) |
地址 |
Hamburg DE |